CLINICAL_TRIALS
trial_result
· 2019-06-11
Clinical Trial Update: Vision Response to Dopamine Replacement [Phase 2]
Summary
Phase 2 trial update for vision response to dopamine replacement in albinism conditions; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Albinism, Oculocutaneous Albinism | Phase 2 | Status: TERMINATED | Results posted: 2019-06-11